1. Home
  2. NEO vs CRTO Comparison

NEO vs CRTO Comparison

Compare NEO & CRTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NeoGenomics Inc.

NEO

NeoGenomics Inc.

HOLD

Current Price

$9.01

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo Criteo S.A.

CRTO

Criteo S.A.

HOLD

Current Price

$19.48

Market Cap

929.9M

ML Signal

HOLD

Company Overview

Basic Information
Metric
NEO
CRTO
Founded
2001
2005
Country
United States
France
Employees
N/A
N/A
Industry
Precision Instruments
Advertising
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
929.9M
IPO Year
2008
2013

Fundamental Metrics

Financial Performance
Metric
NEO
CRTO
Price
$9.01
$19.48
Analyst Decision
Buy
Strong Buy
Analyst Count
7
11
Target Price
$11.14
$35.27
AVG Volume (30 Days)
1.6M
211.2K
Earning Date
04-28-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
38.95
EPS
N/A
2.64
Revenue
N/A
$2,296,692,000.00
Revenue This Year
$10.63
N/A
Revenue Next Year
$9.73
$5.54
P/E Ratio
N/A
$7.29
Revenue Growth
N/A
27.65
52 Week Low
$4.72
$16.15
52 Week High
$13.74
$34.48

Technical Indicators

Market Signals
Indicator
NEO
CRTO
Relative Strength Index (RSI) 59.44 57.25
Support Level $8.68 $19.23
Resistance Level $10.82 $19.85
Average True Range (ATR) 0.50 0.76
MACD 0.14 0.04
Stochastic Oscillator 95.00 75.37

Price Performance

Historical Comparison
NEO
CRTO

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

About CRTO Criteo S.A.

Criteo SA is an ad-tech company in the digital advertising market. Its technology allows retailer advertisers to launch multichannel and cross-device marketing campaigns in real time. With real-time return on investment analysis of the ads, the firm's clients can adjust their marketing strategies dynamically. It has two reportable segments: Retail Media and Performance Media. Retail Media: This segment encompasses revenue generated from brands, agencies, and retailers for the purchase and sale of retail media digital advertising inventory and audiences, and services. Performance Media: This segment encompasses targeting capabilities and supply and AdTech services. The majority of its revenues is generated from the performance media segment.

Share on Social Networks: